You can get 8 credits of optional activities (ADO) participating to conferences ,seminars, workshop, journal club or internship:
- 1 credit 25 hours of internship;
- 0.5 credits conferences and seminars;
- conferences and seminars of your interest can be required as credits sending an email to: : director.medicalbiotech@uniupo.it
A.Y. 2020/2021
1. Title ADO Biomedical aspects of aging" (Prof. Federico Sesti -Rutgers University, USA-) - Prof. Diego Cotella
DIR page: https://www.dir.uniupo.it/course/view.php?id=12810
Credits: 2
Date: 17-18-20 May from 3 pm to 4.45 pm
24 -25 -27 May from 3 to 4.45 pm
Year of enrolment: 1st and 2nd
2. Title ADO: Progress in the development of novel therapies. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax- Dr. Abdurraouf Mokhtar Mahmoud
Credits: 2
Date: 26 May 2021 from 2pm to 4pm
Year of enrolment: 1st Year
2. Title ADO: How to design study protocol; example from randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study - Dr. Abdurraouf Mokhtar Mahmoud
Credits: 2
Date: 18 Jun 2021
Year of enrolment: 2nd Year
3. Title ADO: How to design study protocol; example from randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
Date: 18 June 2021 from 2 pm to 4 pm
Credits: 2
Year of enrolment: 2nd Year
4. Title ADO: How to design study protocol; example from A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
Credits: 2
Date: 28 June 2021 from 2 pm to 4 pm
Year of enrolment: 1st Year
5. Title ADO: Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Date: 09 July 2021 from 2 pm to 4 pm
Credits: 2
Year of enrolment: 1st Year and 2nd Year
6 . Title ADO: KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.
Date: 26 July 2021 from 2 to 4 pm
Credits: 2
Year of enrolment: 1st Year and 2nd Year
7. Title ADO: "Omics in forensic sciences" (Dott.ssa Sarah Gino)
Dir: https://www.dir.uniupo.it/enrol/index.php?id=12851
Credits: 1
Year of enrolment: 2nd Year
